Investor relations
Bio-Works Strengthens its MarketPosition: Strong Start to 2025 and anOrder Book at Record Levels
2024 was a year of challenges for Bio-Works, but we have emerged stronger from the challenges. Hard work and a clear focus have yielded results, and at the beginning of 2025, we have started to see the effects of the organizational changes we have implemented. We are witnessing increasing demand for our products as customers’ inventories of chromatography resins normalize and our customer base expands. In early 2025, we announced new orders with a total value of approximately SEK 22.5 million, and our order book is now at record levels. The increased order intake prompted the board to approve an investment proposal of SEK 1 million in February, which will enable the company to double its production capacity within a year to meet the growing demand.
Our announced cost-saving program of SEK 24 million has exceeded expectations. Operating expenses decreased during the year, and the result improved to SEK -37.4 million (compared to SEK -56.8 million in 2023), despite significantly lower revenue. During the year, we also strengthened the company’s financial position through an oversubscribed rights issue of approximately SEK 39 million, which enabled us to establish a new sales organization and implement other sales and marketing initiatives that have already yielded positive results.
Annual Report 2023
Bio-Works' 2023 Annual Report describes the company's continued journey as it positions itself as the industry's preferred "tailor" of customized solutions, while implementing significant internal changes with the aim of creating an even more agile and focused organization that is adapted to prevailing market conditions.
4 Reasons to invest in Bio-Works




Get the latest
Get the latest
Subscribe to press releases and reports via email.
Check the types of releases you want to subscribe to.
Contact - Investor relations
Investor relations
Arne Hauge
Stock Information
Bio-Works’ stock is listed on the Spotlight Stock Market where it is traded under the ticker BIOWKS. The ISIN code for the stock is SE0007387089.
See the current price for Bio-Works' (BIOWKS) on the Spotlight Stock Market.